In a Rare Head-to-Head Matchup, New Psoriasis Drug Seems a Winner.
Taltz is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is delivered as a subcutaneous injection. The agent comes as either a pre-filled syringe or an autoinjector and can be self-injected after proper training and with physician supervision.